{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:09:23Z","timestamp":1792469363162,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.autrev.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T23:33:53Z","timestamp":1539300833000},"page":"1186-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma \u2013 A review"],"prefix":"10.1016","volume":"17","author":[{"given":"Jos\u00e9 Pedro L.","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Meirinhos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzira","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo M.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Godinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-86-4-394","article-title":"Pulmonary hypertension in the crest syndrome variant of progressive systemic sclerosis (scleroderma)","volume":"86","author":"Salerni","year":"1977","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.autrev.2018.06.009_bb0010","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"R. JS, Murray B, Alan T, et al. 2013 Classification Criteria for Systemic Sclerosis: an American College of Rheumatology\/European League against Rheumatism Collaborative Initiative","volume":"65","author":"Frank","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis","volume":"31","author":"Steen","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2018.06.009_bb0025","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/art.1780331210","article-title":"Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis","volume":"33","author":"Okano","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02030243","article-title":"Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study","volume":"9","author":"Kasukawa","year":"1990","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780350114","article-title":"Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis","volume":"35","author":"Okano","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2018.06.009_bb0045","first-page":"1688","article-title":"Garcia-De La Torre I, Salazar-Paramo M, Vazquez-Del Mercado M, et al. Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis","volume":"22","author":"Fritzler","year":"1995","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-774.x","article-title":"Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis","volume":"105","author":"Ihn","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0055","first-page":"639","article-title":"Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody","volume":"23","author":"Sacks","year":"1996","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0060","first-page":"462","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2018.06.009_bb0065","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients","volume":"35","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.2000.01320.x","article-title":"Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35","volume":"121","author":"Grigolo","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0075","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/1529-0131(200107)44:7<1663::AID-ART290>3.0.CO;2-C","article-title":"Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases","volume":"44","author":"Gunduz","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2018.06.009_bb0080","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0248-8663(01)00433-7","article-title":"D\u00e9pistage de l'hypertension art\u00e9rielle pulmonaire au cours de la scl\u00e9rodermie syst\u00e9mique : \u00e9tude d'une cohorte de 67 patients","volume":"22","author":"Launay","year":"2001","journal-title":"La Revue de medecine interne"},{"issue":"10","key":"10.1016\/j.autrev.2018.06.009_bb0085","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","article-title":"Anti-fibrillarin antibodies in systemic sclerosis","volume":"40","author":"Tormey","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/0891693031000079239","article-title":"Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement","volume":"36","author":"Alessandri","year":"2003","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.10760","article-title":"A comparison between anti-Th\/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement","volume":"48","author":"Mitri","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/art.10914","article-title":"Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension","volume":"49","author":"Ulanet","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0115","first-page":"199","article-title":"Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury","volume":"23","author":"Assous","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/keh486","article-title":"Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001","volume":"44","author":"Hesselstrand","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2018.06.009_bb0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","article-title":"Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension","volume":"60","author":"Tamby","year":"2005","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.06.00152705","article-title":"Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension","volume":"28","author":"Tamby","year":"2006","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.autrev.2018.06.009_bb0140","first-page":"2230","article-title":"Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody","volume":"34","author":"Steen","year":"2007","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.07-2324","article-title":"Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis","volume":"134","author":"Steen","year":"2008","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.2007.08392.x","article-title":"The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"158","author":"Hamaguchi","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/03009740801978871","article-title":"The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis","volume":"37","author":"Kampolis","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.009_bb0160","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00296-009-1107-0","article-title":"Clinical significance of antiphospholipid antibodies in Indian scleroderma patients","volume":"30","author":"Gupta","year":"2009","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.autrev.2018.06.009_bb0170","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/art.24684","article-title":"Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients","volume":"60","author":"Boin","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0175","first-page":"141","article-title":"Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis","volume":"158","author":"Marie","year":"2008","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.autrev.2018.06.009_bb0180","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/ard.2007.073981","article-title":"Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-Centre case-control study","volume":"67","author":"Rozman","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00403-005-0603-7","article-title":"Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis","volume":"297","author":"Hayakawa","year":"2005","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.009_bb0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.62.6.589","article-title":"More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis","volume":"62","author":"Antonioli","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2018.06.009_bb0195","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/ard.2003.016659","article-title":"Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis","volume":"63","author":"Hasegawa","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0200","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.2008.104299","article-title":"Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease","volume":"69","author":"Terrier","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3899\/jrheum.090677","article-title":"Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study","volume":"37","author":"Meyer","year":"2010","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0215","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.10-2473","article-title":"Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease","volume":"140","author":"Launay","year":"2011","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.009_bb0220","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1590\/S0365-05962011000600003","article-title":"Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil","volume":"86","author":"Skare","year":"2011","journal-title":"An Bras Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2018.06.009_bb0225","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.110071","article-title":"Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis","volume":"38","author":"Sharif","year":"2011","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2018.06.009_bb0230","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1136\/ard.2011.153130","article-title":"Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease","volume":"70","author":"Grader-Beck","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0235","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/annrheumdis-2011-200265","article-title":"The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH","volume":"71","author":"Clements","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0240","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/s10165-011-0515-7","article-title":"Clinical features of 405 Japanese patients with systemic sclerosis","volume":"22","author":"Hashimoto","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0245","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/rheum.111133","article-title":"Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis","volume":"39","author":"Hudson","year":"2012","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0250","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.009_bb0260","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10067-011-1930-z","article-title":"Anti-cyclic citrullinated peptide antibodies in scleroderma patients","volume":"31","author":"Polimeni","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.06.009_bb0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-94-007-4549-0_19","article-title":"Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis","volume":"756","author":"Lewandowska","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0270","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.injr.2013.12.002","article-title":"Anticardiolipin antibodies are associated with pulmonary arterial hypertension in Algerian systemic scleroderma patients","volume":"9","author":"Mellal","year":"2014","journal-title":"Indian Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5005\/ijcdas-56-4-231","article-title":"A study on pulmonary complications of systemic sclerosis in eastern India","volume":"56","author":"Ghosh","year":"2014","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.06.009_bb0290","unstructured":"Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, et al. The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis. Clinical and experimental rheumatology. 2014;32(6 Suppl 86):S-133-7."},{"issue":"6","key":"10.1016\/j.autrev.2018.06.009_bb0295","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2018.06.009_bb0300","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.semarthrit.2014.11.006","article-title":"Antinuclear antibody-negative systemic sclerosis","volume":"44","author":"Salazar","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00393-014-1391-2","article-title":"Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension","volume":"74","author":"Tao","year":"2015","journal-title":"Z Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0310","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.semarthrit.2015.06.011","article-title":"Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry","volume":"45","author":"Hinchcliff","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1346-8138.12722","article-title":"Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies","volume":"42","author":"Motegi","year":"2015","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semarthrit.2015.04.009","article-title":"Thinking outside the box--the associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect","volume":"45","author":"Srivastava","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0325","first-page":"1","article-title":"Screening of pulmonary hypertension in a Spanish cohort of patients with systemic sclerosis","volume":"146","author":"Garcia Hernandez","year":"2016","journal-title":"Medicina clinica"},{"issue":"35","key":"10.1016\/j.autrev.2018.06.009_bb0330","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004713","article-title":"Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations","volume":"95","author":"Hoa","year":"2016","journal-title":"Medicine"},{"issue":"25","key":"10.1016\/j.autrev.2018.06.009_bb0335","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003931","article-title":"Subspecificities of anticentromeric protein a antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease","volume":"95","author":"Perosa","year":"2016","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0340","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/art.39432","article-title":"Characteristics and Survival of Anti-U1 RNP Antibody-positive patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension","volume":"68","author":"Sobanski","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2018.06.009_bb0345","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/1756-185X.12484","article-title":"Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study","volume":"19","author":"Tozkir","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0350","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3899\/jrheum.160867","article-title":"Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative analyses from an Unselected, prospective Patient Cohort","volume":"44","author":"Hoffmann-Vold","year":"2017","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0355","first-page":"1081","article-title":"Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies","volume":"56","author":"Markusse","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2018.06.009_bb0360","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10067-016-3504-6","article-title":"Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity","volume":"36","author":"Michelfelder","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/sji.12510","article-title":"The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic Sclerosis","volume":"85","author":"Tall","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2018.06.009_bb0370","unstructured":"Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, et al. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. Clinical and experimental rheumatology. 2017;35 Suppl 106(4):114\u201321."},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0375","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/acr.22163","article-title":"Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement","volume":"66","author":"Kaji","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.autrev.2018.06.009_bb0380","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00296-016-3639-4","article-title":"Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations","volume":"37","author":"Ilgen","year":"2017","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0385","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0390","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4274\/tjh.2012.0059","article-title":"Antiphospholipid antibodies and systemic scleroderma","volume":"30","author":"Toure","year":"2013","journal-title":"Turk J Haematol"},{"issue":"3","key":"10.1016\/j.autrev.2018.06.009_bb0395","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2018.01.006","article-title":"Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype","volume":"17","author":"Fritzler","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2 Suppl 71","key":"10.1016\/j.autrev.2018.06.009_bb0400","first-page":"S12","article-title":"Anti-PM-Scl antibody in patients with systemic sclerosis","volume":"30","author":"Koschik","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0405","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/08916934.2011.592886","article-title":"Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients","volume":"44","author":"Rodriguez-Reyna","year":"2011","journal-title":"Autoimmunity"},{"issue":"4 Suppl 91","key":"10.1016\/j.autrev.2018.06.009_bb0410","first-page":"S131","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0415","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/art.1780250708","article-title":"Anti-nRNP and anti-Sm antibodies","volume":"25","author":"Sharp","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13317-011-0015-y","article-title":"Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients","volume":"2","author":"Morozzi","year":"2011","journal-title":"Auto Immun Highlights"},{"issue":"8","key":"10.1016\/j.autrev.2018.06.009_bb0425","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/rheumatology\/kes055","article-title":"Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population","volume":"51","author":"Low","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0430","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.009_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","article-title":"Survival in scleroderma: results from the population-based South Australian Register","volume":"41","author":"Hissaria","year":"2011","journal-title":"Intern Med J"},{"issue":"43","key":"10.1016\/j.autrev.2018.06.009_bb0440","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001728","article-title":"Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of death","volume":"94","author":"Simeon-Aznar","year":"2015","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.autrev.2018.06.009_bb0445","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N","article-title":"Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit","volume":"42","author":"Bryan","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2018.06.009_bb0450","first-page":"2454","article-title":"Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis","volume":"28","author":"Jacobsen","year":"2001","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2018.06.009_bb0455","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3899\/jrheum.100956","article-title":"Late-age onset systemic sclerosis","volume":"38","author":"Manno","year":"2011","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2018.06.009_bb0460","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2017.05.023","article-title":"Auto-antibodies and cancer in systemic sclerosis","volume":"16","author":"Boonstra","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.autrev.2018.06.009_bb0465","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2018.06.009_bb0470","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.autrev.2017.07.019","article-title":"Role of anti-receptor autoantibodies in pathophysiology of scleroderma","volume":"16","author":"Berger","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2018.06.009_bb0475","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2018.06.009_bb0480","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.semarthrit.2016.10.004","article-title":"Clinical relevance of antiphospholipid antibodies in systemic sclerosis: a systematic review and meta-analysis","volume":"46","author":"Merashli","year":"2017","journal-title":"Semin Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218302325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:13:25Z","timestamp":1761599605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218302325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1568997218302325"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.06.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734227481.793568469","asserted-by":"object"}]},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}